Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
247 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hepatitis B"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
2 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
3 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
4 Recruiting Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
Condition: Chronic Hepatitis B
Interventions: Drug: tenofovir disoproxil fumarate 300mg per day;   Drug: Placebo
5 Not yet recruiting Emtricitabine for Naive Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
6 Not yet recruiting Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention: Drug: Emtricitabine
7 Not yet recruiting Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients
Conditions: Hepatitis B, Chronic;   Pregnancy
Intervention: Drug: Emtricitabine
8 Recruiting Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection
Conditions: Hepatitis B, Chronic;   Liver Fibrosis
Intervention: Drug: Treatment with entecavir(Baraclude®)
9 Not yet recruiting Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
Conditions: Lymphoma;   Chronic Hepatitis B
Intervention:
10 Unknown  Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon alfa-2a;   Drug: Placebo and peginterferon
11 Unknown  Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks);   Drug: Peginterferon (Pegasys) (96 weeks);   Drug: Peginterferon (Pegasys) (48 weeks)
12 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
Intervention:
13 Unknown  A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B
Conditions: Hepatitis B, Chronic;   Liver Diseases;   Virus Diseases;   Hepatitis;   Diffuse Hepatic Disease
Intervention: Device: Liquid Acupuncture (Herb Acupoint Injection)
14 Unknown  Prednisolone Priming Study in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Prednisolone;   Drug: Placebo priming
15 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
16 Unknown  Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
Conditions: Liver Cirrhosis;   Chronic Hepatitis B
Intervention: Drug: telbivudine
17 Unknown  Adolescents' Response to Hepatitis B Vaccine Booster Dose
Condition: Hepatitis B
Intervention: Biological: hepatitis B vaccine
18 Recruiting Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
19 Recruiting Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention:
20 Recruiting Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy
Condition: Chronic Hepatitis B
Interventions: Drug: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly;   Drug: Nucleos(t)ide analogue therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years